Advertisement

Topics

Clinical Trial Begins For Promising New Post-Menopausal Therapy Treating Vasomotor Symptoms

09:37 EDT 17 Apr 2018 | BioMedReports - Blog

FP-101 is an orally dosed, non-hormonal, non-herbal, non-antidepressant formulation of a compound that has known mechanisms of action, is already FDA-approved for another undisclosed indication,

Read more...

Original Article: Clinical Trial Begins For Promising New Post-Menopausal Therapy Treating Vasomotor Symptoms

NEXT ARTICLE

More From BioPortfolio on "Clinical Trial Begins For Promising New Post-Menopausal Therapy Treating Vasomotor Symptoms"

Advertisement
Quick Search
Advertisement
Advertisement